Article Versions Notes

Mutevedzi PC, Lokotfwako V, Kwatra G, Maphalala G, Baillie V, Dlamini L, Dlamini S, Mhlanga F, Dlamini T, Nhlabatsi N, et al. Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave. COVID. 2024; 4(3):317-333. https://doi.org/10.3390/covid4030021

Mutevedzi, Portia C., Vusie Lokotfwako, Gaurav Kwatra, Gugu Maphalala, Vicky Baillie, Lindiwe Dlamini, Senzokuhle Dlamini, Fortune Mhlanga, Tenelisiwe Dlamini, Nhlanhla Nhlabatsi, and et al. 2024. "Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave" COVID 4, no. 3: 317-333. https://doi.org/10.3390/covid4030021

Mutevedzi, P. C., Lokotfwako, V., Kwatra, G., Maphalala, G., Baillie, V., Dlamini, L., Dlamini, S., Mhlanga, F., Dlamini, T., Nhlabatsi, N., Nunes, M. C., Zwane, S., & Madhi, S. A. (2024). Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave. COVID, 4(3), 317-333. https://doi.org/10.3390/covid4030021